The expert in charge of two separate Australian clinical trials of coronavirus vaccine candidates says the latest vaccine agreement announced by the federal government is vital in helping the country eventually reopen fully next year.
Prime Minister Scott Morrison confirmed on Thursday that Australia would spend $1.5 billion to add the Novavax and the Pfizer vaccines to the country’s eventual pool of available vaccines.
Australia now has agreements for four separate vaccine candidates, including the two announced on Thursday along with the University of Queensland vaccine and the University of Oxford/AstraZeneca candidate.
Paul Griffin, a clinical disease specialist and the local lead clinical trial investigator for Nucleus Network, which is running the Phase 1 and 2 studies of the Novavax vaccine as well as for the UQ/ CSL candidate, said the deal announced by the federal government did not detract from the deals already announced.
I run this site in my spare time and thoroughly enjoy giving you all positive news! If you’ve enjoyed the site we’d love for you to help me share the good news far and wide, share us on Reddit, your Facebook or your Twitter and spread a little positivity around.
ENJOY FEEL GOOD, INSPIRING STORIES AND VIDEOS ?
Our new page here is just what you need, with just good news, feel good stories unrelated to COVID.